妇科疾病影像学(14):卵巢透明细胞癌的临床与超声特征
这项回顾性研究纳入11个超声中心的152例经组织学确诊的卵巢纯透明细胞癌患者,采用IOTA术语描述超声图像。肿瘤多为单侧、含实性成分,60.5%为FIGO I期;起源于子宫内膜异位症者更年轻,囊液磨玻璃回声更常见。
要点
- 152例卵巢纯透明细胞癌中92/152(60.5%)为FIGO I期,128/152(84.2%)为单侧肿瘤。
- 超声上全部肿瘤含实性成分,36/152(23.7%)为完全实性肿块,病灶最大径中位117(范围25-310)mm。
- 58/152(38.2%)有乳头状突起,其中51/56(91.1%)乳头状突起可见血流。
核心结论
- 卵巢纯透明细胞癌通常诊断于早期,典型表现为含实性成分的单侧大肿块。
- 起源于子宫内膜异位症的透明细胞癌患者较其他透明细胞癌患者年轻,且更常表现为囊液磨玻璃回声。
研究设计与样本
- 回顾性研究,涉及11个超声中心。
- 从国际卵巢肿瘤分析(IOTA)数据库识别1999年至2016年间由经验丰富超声检查者行术前超声、经组织学确诊为卵巢纯透明细胞癌的105例患者。
- 另从参与中心妇科肿瘤科数据库回顾性识别1999年至2016年间诊断、有完整术前超声报告的纯透明细胞癌47例患者。
- 全部肿瘤超声图像采用IOTA术语描述,分析全组及有无组织学证实子宫内膜异位症、有肿瘤起源于子宫内膜异位症证据患者的临床与超声特征。
主要发现
- 152例患者年龄中位53.5(范围28-92)岁,92/152(60.5%)为FIGO I期。
- 128/152(84.2%)肿瘤为单侧;全部肿瘤含实性成分,36/152(23.7%)为完全实性肿块。
- 病灶最大径中位117(范围25-310)mm;58/152(38.2%)有乳头状突起,其中51/56(91.1%)乳头状突起可见血流。
- 130/152例有组织学盆腔子宫内膜异位症信息,其中54例(41.5%)存在子宫内膜异位症,24/130(18.6%)判断肿瘤起源于子宫内膜异位症。
- 有肿瘤起源于子宫内膜异位症证据者较无证据者年轻(中位47.5 vs 55.0岁),囊液磨玻璃回声更常见(10/20 vs 13/79,50.0% vs 16.5%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the clinical and ultrasound characteristics of ovarian pure clear cell carcinoma. METHODS: This was a retrospective study involving data from 11 ultrasound centers. From the International Ovarian Tumor Analysis (IOTA) database, 105 patients who had undergone preoperative ultrasound examination by an experienced ultrasound examiner between 1999 and 2016 were identified with a histologically confirmed pure clear cell carcinoma of the ovary. An additional 47 patients diagnosed with pure clear cell carcinoma between 1999 and 2016 and with available complete preoperative ultrasound reports were identified retrospectively from the databases of the departments of gynecological oncology in the participating centers. The ultrasound images of all tumors were described using IOTA terminology. Clinical and ultrasound characteristics were analyzed for the whole group, and separately, for patients with and those without histologically confirmed endometriosis, and for patients with evidence of tumor developing from endometriosis. RESULTS: Median age of the 152 patients was 53.5 (range, 28-92) years and 92/152 (60.5%) tumors were FIGO Stage I. Most tumors (128/152, 84.2%) were unilateral. On ultrasound examination, all tumors contained solid components and 36/152 (23.7%) were completely solid masses. The median largest diameter of the lesion was 117 (range, 25-310) mm. Papillary projections were present in 58/152 (38.2%) masses and, in most of these (51/56, 91.1%), vascularized papillary projections were seen. Information regarding the presence, site and type of pelvic endometriosis at histology was available for 130/152 patients. Endometriosis was noted in 54 (41.5%) of these. In 24/130 (18.6%) patients, the tumor was judged to have developed from endometriosis. Patients with, compared to those without, evidence of tumor developing from endometriosis were younger (median 47.5 vs 55.0 years, respectively), and ground-glass echogenicity of cyst fluid was more common in pure clear cell cancers developing from endometriosis (10/20 vs 13/79 (50.0% vs 16.5%), respectively). CONCLUSIONS: Ovarian pure clear cell carcinoma is usually diagnosed at an early stage and typically appears as a large unilateral mass with solid components. Patients with clear cell carcinoma developing from endometriosis are younger than other patients with clear cell carcinoma, and clear cell cancers developing from endometriosis more often manifest ground-glass echogenicity of cyst fluid. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Pozzati F, Moro F, Pasciuto T, et al. Imaging in gynecological disease (14): clinical and ultrasound characteristics of ovarian clear cell carcinoma. Ultrasound Obstet Gynecol. 2018. PMID: 29978567. doi:10.1002/uog.19171
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。